This opinion cited by 15 cases:
In Re Cyclobenzaprine Hydrochloride Extended-Release Capsule Patent Litigation , 693 F. Supp. 2d 409 ( 2010 )
Boston Scientific Corp. v. Johnson & Johnson Inc. , 532 F. Supp. 2d 648 ( 2008 )
1st Source Bank v. Merritt , 759 F. Supp. 2d 505 ( 2011 )
Freres v. SPI Pharma, Inc. , 629 F. Supp. 2d 374 ( 2009 )
Intel Corp. v. Broadcom Corp. , 167 F. Supp. 2d 692 ( 2001 )
Medtronic AVE Inc v. Advanced Cardiovascular Systems, Inc. ( 2001 )
Patrick Blanks v. Fluor Corporation ( 2014 )
Viega GmbH v. Eighth Jud. Dist. Ct. , 2014 NV 40 ( 2014 )
Medtronic Ave, Inc. v. Advanced Cardiovascular Systems, Inc. , 247 F.3d 44 ( 2001 )
Patrick Blanks v. Fluor Corporation , 2014 Mo. App. LEXIS 1013 ( 2014 )
Amgen, Inc. v. Ariad Pharmaceuticals, Inc. , 513 F. Supp. 2d 34 ( 2007 )
Chrysler Corp. v. Chaplake Holdings, Ltd. , 2003 Del. LEXIS 269 ( 2003 )
Affymetrix, Inc. v. Synteni, Inc. , 28 F. Supp. 2d 192 ( 1998 )
Otto Candies, LLC v. KPMG, LLP ( 2020 )
Cephalon, Inc. v. Watson Pharmaceuticals, Inc. , 629 F. Supp. 2d 338 ( 2009 )
